Key result
Chronic disease management achieves treatment success in only ~23% of patients despite high medication adherence.
Cross-Sectional (n=638)
Yes
Answers are grounded in this paper and cite their sources.
OBJECTIVES: To determine medication use patterns and associated health outcomes in Chinese individuals with diabetes, hypertension or hyperlipidaemia. METHODS: This community-based cross-sectional study was done in a north China city of 300 000 people. Participants were recruited by poster and phone call through Community Health Centres. Data were collected on 638 Chinese individuals. Interviews were done to screen for disease and health behaviours. Fasting blood was collected and analyzed. KEY FINDINGS: Participants' average age was 52 years. Self-reported prevalence of type 2 diabetes, hypertension and hyperlipidaemia was 9.6, 29.9 and 20.5% respectively. Medication adherence was found among 88, 60 and 81.5% of individuals with diabetes, hypertension and hyperlipidaemia respectively. Treatment success, as defined by medication adherence and treatment to goal was achieved by 21, 23 and 10% of diabetic, hypertensive and hyperlipidaemic patients. CONCLUSIONS: A large proportion of individuals with chronic disease in this China-based study were not being successfully treated, putting them at high risk for poor health outcomes. In this urban China setting, healthcare services need to be strengthened in order to achieve better treatment outcomes among chronic disease patients. It is recommended that community pharmacists contribute to improving these outcomes through participation in patient education, medication reconciliation and disease state management.
No takes yet. Share an insight, caveat, or question.
Strand et al. (2016) conducted a cross-sectional in Diabetes, hypertension, or hyperlipidaemia (n=638). Chronic disease medication utilization and adherence was evaluated on Medication adherence and treatment success (defined as medication adherence and treatment to goal). Chronic disease management in urban Chinese patients yielded low treatment success rates of 21% in diabetes, 23% in hypertension, and 10% in hyperlipidaemia despite 60%-88% adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: